Casandra L. Slavens, ARNP

Casandra Slavens practices at Skin Cancer Center Of Central Florida, P.a. in Summerfield, Florida.

Casandra Slavens' NPI, 1548596083, was assigned on October 18, 2009. Casandra Slavens holds Florida license 9210033.

Casandra Slavens' primary practice is Skin Cancer Center of Central Florida, P.a., at 10973 Se 175th Pl Ste 100 Suite 100, Summerfield, FL 34491. The practice phone is (352) 259-6553.

Casandra Slavens' primary practice is Skin Cancer Center Of Central Florida, P.a. in Summerfield, Florida. The medical group on file is Skin Cancer Center of Central Florida. Dmand AI also links Casandra Slavens to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Casandra Slavens practices. Vendor and product names are available with a free account.

Dermatology is Casandra Slavens' primary specialty in the NPI Registry, under taxonomy code 207N00000X. Casandra Slavens is licensed in Florida.

Dmand AI lists acute skin infection, ankle or foot injury, benign or precancerous skin growths, contact dermatitis, eyelid inflammation, itchy rashes, joint cyst and minor injury to a limb among the conditions Casandra Slavens treats.

CMS data shows 4,117 Medicare services from Casandra Slavens across 16 procedure codes in 2024, for 774 Medicare patients. Medicare paid $116,180 for them. Every service was in an office.

CMS counts 774 Medicare patients who saw Casandra Slavens in 2024. The largest group is 75 to 84, with 394 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 1.23, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Casandra Slavens' median patient age at 79, with 54% women.

In 2024, Casandra Slavens wrote 507 Medicare Part D claims for 316 patients. 98% of them were for generic drugs. CMS names the drug for 400 of them, across 8 drugs with 11 or more claims each, at $6,226 in total drug cost. In 2023, CMS named 386 claims across 8 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 98 out of 100 for Casandra Slavens for performance year 2024, reported as part of a group. Casandra Slavens accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 8 general payments to Casandra Slavens from 5 drug and device companies from 2021 to 2025. Food and beverage make up the largest share, 100% of the total. Regeneron Pharmaceuticals, Inc. paid the most, $65.